A time-resolved proteomic and prognostic map of COVID-19
Standard
A time-resolved proteomic and prognostic map of COVID-19. / Demichev, Vadim; Tober-Lau, Pinkus; Lemke, Oliver; Nazarenko, Tatiana; Thibeault, Charlotte; Whitwell, Harry; Röhl, Annika; Freiwald, Anja; Szyrwiel, Lukasz; Ludwig, Daniela; Correia-Melo, Clara; Aulakh, Simran Kaur; Helbig, Elisa T; Stubbemann, Paula; Lippert, Lena J; Grüning, Nana-Maria; Blyuss, Oleg; Vernardis, Spyros; White, Matthew; Messner, Christoph B; Joannidis, Michael; Sonnweber, Thomas; Klein, Sebastian J; Pizzini, Alex; Wohlfarter, Yvonne; Sahanic, Sabina; Hilbe, Richard; Schaefer, Benedikt; Wagner, Sonja; Mittermaier, Mirja; Machleidt, Felix; Garcia, Carmen; Ruwwe-Glösenkamp, Christoph; Lingscheid, Tilman; Bosquillon de Jarcy, Laure; Stegemann, Miriam S; Pfeiffer, Moritz; Jürgens, Linda; Denker, Sophy; Zickler, Daniel; Enghard, Philipp; Zelezniak, Aleksej; Campbell, Archie; Hayward, Caroline; Porteous, David J; Marioni, Riccardo E; Uhrig, Alexander; Müller-Redetzky, Holger; Zoller, Heinz; Löffler-Ragg, Judith; Keller, Markus A; Tancevski, Ivan; Timms, John F; Zaikin, Alexey; Hippenstiel, Stefan; Ramharter, Michael; Witzenrath, Martin; Suttorp, Norbert; Lilley, Kathryn; Mülleder, Michael; Sander, Leif Erik; Ralser, Markus; Kurth, Florian; Pa-COVID Study Group.
In: CELL SYST, Vol. 12, No. 8, 18.08.2021, p. 780-794.e7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A time-resolved proteomic and prognostic map of COVID-19
AU - Demichev, Vadim
AU - Tober-Lau, Pinkus
AU - Lemke, Oliver
AU - Nazarenko, Tatiana
AU - Thibeault, Charlotte
AU - Whitwell, Harry
AU - Röhl, Annika
AU - Freiwald, Anja
AU - Szyrwiel, Lukasz
AU - Ludwig, Daniela
AU - Correia-Melo, Clara
AU - Aulakh, Simran Kaur
AU - Helbig, Elisa T
AU - Stubbemann, Paula
AU - Lippert, Lena J
AU - Grüning, Nana-Maria
AU - Blyuss, Oleg
AU - Vernardis, Spyros
AU - White, Matthew
AU - Messner, Christoph B
AU - Joannidis, Michael
AU - Sonnweber, Thomas
AU - Klein, Sebastian J
AU - Pizzini, Alex
AU - Wohlfarter, Yvonne
AU - Sahanic, Sabina
AU - Hilbe, Richard
AU - Schaefer, Benedikt
AU - Wagner, Sonja
AU - Mittermaier, Mirja
AU - Machleidt, Felix
AU - Garcia, Carmen
AU - Ruwwe-Glösenkamp, Christoph
AU - Lingscheid, Tilman
AU - Bosquillon de Jarcy, Laure
AU - Stegemann, Miriam S
AU - Pfeiffer, Moritz
AU - Jürgens, Linda
AU - Denker, Sophy
AU - Zickler, Daniel
AU - Enghard, Philipp
AU - Zelezniak, Aleksej
AU - Campbell, Archie
AU - Hayward, Caroline
AU - Porteous, David J
AU - Marioni, Riccardo E
AU - Uhrig, Alexander
AU - Müller-Redetzky, Holger
AU - Zoller, Heinz
AU - Löffler-Ragg, Judith
AU - Keller, Markus A
AU - Tancevski, Ivan
AU - Timms, John F
AU - Zaikin, Alexey
AU - Hippenstiel, Stefan
AU - Ramharter, Michael
AU - Witzenrath, Martin
AU - Suttorp, Norbert
AU - Lilley, Kathryn
AU - Mülleder, Michael
AU - Sander, Leif Erik
AU - Ralser, Markus
AU - Kurth, Florian
AU - Pa-COVID Study Group
N1 - Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2021/8/18
Y1 - 2021/8/18
N2 - COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. We characterized the time-dependent progression of the disease in 139 COVID-19 inpatients by measuring 86 accredited diagnostic parameters, such as blood cell counts and enzyme activities, as well as untargeted plasma proteomes at 687 sampling points. We report an initial spike in a systemic inflammatory response, which is gradually alleviated and followed by a protein signature indicative of tissue repair, metabolic reconstitution, and immunomodulation. We identify prognostic marker signatures for devising risk-adapted treatment strategies and use machine learning to classify therapeutic needs. We show that the machine learning models based on the proteome are transferable to an independent cohort. Our study presents a map linking routinely used clinical diagnostic parameters to plasma proteomes and their dynamics in an infectious disease.
AB - COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. We characterized the time-dependent progression of the disease in 139 COVID-19 inpatients by measuring 86 accredited diagnostic parameters, such as blood cell counts and enzyme activities, as well as untargeted plasma proteomes at 687 sampling points. We report an initial spike in a systemic inflammatory response, which is gradually alleviated and followed by a protein signature indicative of tissue repair, metabolic reconstitution, and immunomodulation. We identify prognostic marker signatures for devising risk-adapted treatment strategies and use machine learning to classify therapeutic needs. We show that the machine learning models based on the proteome are transferable to an independent cohort. Our study presents a map linking routinely used clinical diagnostic parameters to plasma proteomes and their dynamics in an infectious disease.
KW - Age Factors
KW - Biomarkers/analysis
KW - Blood Cell Count
KW - Blood Gas Analysis
KW - COVID-19/pathology
KW - Disease Progression
KW - Enzyme Activation
KW - Humans
KW - Inflammation/pathology
KW - Machine Learning
KW - Prognosis
KW - Proteome/physiology
KW - Proteomics
KW - SARS-CoV-2/immunology
U2 - 10.1016/j.cels.2021.05.005
DO - 10.1016/j.cels.2021.05.005
M3 - SCORING: Journal article
C2 - 34139154
VL - 12
SP - 780-794.e7
JO - CELL SYST
JF - CELL SYST
SN - 2405-4712
IS - 8
ER -